Trial Profile
A Study of the Effect of Oral, Multiple‐Dose 300 mg and 900 mg Gemcabene (CI‐1027) Administration on the Steady‐State Pharmacokinetics of Atorvastatin 80 mg
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Gemcabene (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Gemphire Therapeutics
- 15 Sep 2016 New trial record